NO20053312L - Benzofuranderivat. - Google Patents

Benzofuranderivat.

Info

Publication number
NO20053312L
NO20053312L NO20053312A NO20053312A NO20053312L NO 20053312 L NO20053312 L NO 20053312L NO 20053312 A NO20053312 A NO 20053312A NO 20053312 A NO20053312 A NO 20053312A NO 20053312 L NO20053312 L NO 20053312L
Authority
NO
Norway
Prior art keywords
optionally substituted
compound
alkyl
nitrogen
benzofuran derivative
Prior art date
Application number
NO20053312A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053312D0 (no
Inventor
Masao Ohkuchi
Seiichi Sato
Tomoyuki Koshi
Natsuyo Kumai
Kyoko Yasuoka
Masahiro Tamura
Junko Totsuka
Toshimi Mizoguchi
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20053312D0 publication Critical patent/NO20053312D0/no
Publication of NO20053312L publication Critical patent/NO20053312L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20053312A 2003-03-07 2005-07-06 Benzofuranderivat. NO20053312L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45256403P 2003-03-07 2003-03-07
PCT/JP2004/002633 WO2004078751A1 (ja) 2003-03-07 2004-03-03 ベンゾフラン誘導体

Publications (2)

Publication Number Publication Date
NO20053312D0 NO20053312D0 (no) 2005-07-06
NO20053312L true NO20053312L (no) 2005-10-04

Family

ID=32962732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053312A NO20053312L (no) 2003-03-07 2005-07-06 Benzofuranderivat.

Country Status (16)

Country Link
US (1) US7314877B2 (xx)
EP (1) EP1602655A4 (xx)
JP (1) JP4528722B2 (xx)
KR (1) KR20050105982A (xx)
CN (1) CN1326852C (xx)
AU (1) AU2004218161B9 (xx)
BR (1) BRPI0407519A (xx)
CA (1) CA2512280A1 (xx)
HK (1) HK1087105A1 (xx)
MX (1) MXPA05009500A (xx)
MY (1) MY137964A (xx)
NO (1) NO20053312L (xx)
NZ (1) NZ541064A (xx)
RU (1) RU2328495C2 (xx)
TW (1) TWI281397B (xx)
WO (1) WO2004078751A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05009972A (es) 2003-03-18 2005-11-04 Kowa Co Derivado de fenilpiridazina soluble en agua y medicina que contiene el mismo.
EP1604988A1 (en) * 2004-05-18 2005-12-14 Sanofi-Aventis Deutschland GmbH Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
ZA200806266B (en) * 2006-03-09 2010-05-26 Om Pharma Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines
FR2941947B1 (fr) * 2009-02-12 2011-03-25 Sanofi Aventis Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique
CN101845032B (zh) * 2010-06-03 2011-11-30 广东德鑫制药有限公司 一种酚类化合物及用途
JP5648058B2 (ja) 2010-07-22 2015-01-07 扶桑薬品工業株式会社 ベンゾフラノン化合物およびそれを含む医薬組成物
SG191945A1 (en) * 2011-01-14 2013-08-30 Vertex Pharma Process of making gyrase and topoisomerase iv inhibitors
US9844766B2 (en) 2011-10-31 2017-12-19 Korea Electric Power Corporation Solid carbon dioxide absorbent including amine or a compound thereof for use in the capturing process of dry carbon dioxide, and method for manufacturing same
KR101652199B1 (ko) * 2015-06-03 2016-08-30 영남대학교 산학협력단 신규 벤조퓨란온 유도체 화합물, 이의 제조 방법 및 이를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 조성물
KR20180006522A (ko) 2016-07-07 2018-01-18 삼성디스플레이 주식회사 액정 조성물 및 이를 포함하는 액정 표시 장치
CN108440468B (zh) * 2018-04-17 2022-09-23 南华大学 2-(苯并呋喃-5-基)苯酚及其作为抗癌药物的应用
ES2958954T3 (es) 2018-11-06 2024-02-16 Edgewise Therapeutics Inc Compuestos de piridazinona y usos de los mismos

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3093507B2 (ja) * 1993-02-15 2000-10-03 キヤノン株式会社 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
AU2521597A (en) 1996-04-12 1997-11-07 Sumitomo Pharmaceuticals Company, Limited Piperidinylpyramidine derivatives
JP3337992B2 (ja) 1997-11-04 2002-10-28 ファイザー製薬株式会社 ５−置換ピコリン酸化合物及びその製造方法
EP2017266A1 (en) 1997-11-19 2009-01-21 Kowa Co., Ltd. Pyridazine derivatives and medicines containing the same as effective ingredients
TWI241295B (en) 1998-03-02 2005-10-11 Kowa Co Pyridazine derivative and medicine containing the same as effect component
JP2000247959A (ja) 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
JP2000290261A (ja) * 1999-04-01 2000-10-17 Mitsui Chemicals Inc ジヒドロピリダジノン誘導体およびそれを有効成分として含有する腫瘍壊死因子産生抑制剤
WO2001022966A1 (en) 1999-09-30 2001-04-05 Smithkline Beecham Corporation Caspases and apoptosis
JP4548882B2 (ja) 1999-11-30 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン化合物
JP4502435B2 (ja) 1999-11-30 2010-07-14 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン系化合物
JP4548884B2 (ja) 1999-12-03 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン誘導体
SK11202002A3 (sk) 2000-02-09 2003-03-04 Hokuriku Seiyaku Co., Ltd. Deriváty 1H-imidazopyridínu
CN1404474A (zh) 2000-02-21 2003-03-19 阿斯特拉曾尼卡有限公司 芳基哌嗪和芳基哌啶及其作为金属蛋白酶抑制剂的应用
EP1265855A1 (en) 2000-02-24 2002-12-18 Smithkline Beecham Plc Novel cd23 inhibitors
CA2397661C (en) 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
US6664256B1 (en) 2000-07-10 2003-12-16 Kowa Co., Ltd. Phenylpyridazine compounds and medicines containing the same
US6861428B2 (en) 2001-09-26 2005-03-01 Kowa Co., Ltd. Water-soluble phenylpyridazine compounds and compositions containing the same
CN1304379C (zh) 2001-09-26 2007-03-14 兴和株式会社 水溶性苯基哒嗪衍生物及含有该衍生物的药物
JP3774710B2 (ja) 2003-06-27 2006-05-17 横浜ゴム株式会社 空気入りタイヤ

Also Published As

Publication number Publication date
BRPI0407519A (pt) 2006-02-14
RU2328495C2 (ru) 2008-07-10
MY137964A (en) 2009-04-30
RU2005131018A (ru) 2006-02-10
US7314877B2 (en) 2008-01-01
MXPA05009500A (es) 2005-10-18
AU2004218161B2 (en) 2009-10-29
CA2512280A1 (en) 2004-09-16
CN1756753A (zh) 2006-04-05
AU2004218161B9 (en) 2009-11-26
WO2004078751A1 (ja) 2004-09-16
KR20050105982A (ko) 2005-11-08
US20060189621A1 (en) 2006-08-24
HK1087105A1 (en) 2006-10-06
TWI281397B (en) 2007-05-21
JPWO2004078751A1 (ja) 2006-06-08
EP1602655A4 (en) 2010-06-09
JP4528722B2 (ja) 2010-08-18
CN1326852C (zh) 2007-07-18
EP1602655A1 (en) 2005-12-07
NO20053312D0 (no) 2005-07-06
TW200420292A (en) 2004-10-16
AU2004218161A1 (en) 2004-09-16
NZ541064A (en) 2007-09-28

Similar Documents

Publication Publication Date Title
NO20053312L (no) Benzofuranderivat.
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
NO20054852L (no) GFAT inhibitorer
CY1109441T1 (el) Ενδιαμεσα προϊοντα για την παραγωγη διοξανιου-2-αλκυλκαρβαμικου
NO20082561L (no) Nye koblede pyrrolderivater
TW200500339A (en) Pyrrolidine derivatives, and process for the preparation
MXPA02011370A (es) Iminoazinas substituidas.
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MXPA05011962A (es) Oxiarenos substituidos.
MX2009006334A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona.
DE602004031410D1 (de) Inden derivate als pharmazeutika
EA200500191A1 (ru) Кристаллический 2,5-дион-3-(1-метил-1h-индол-3-ил)-4-[1-(пиридин-2-илметил)пиперидин-4-ил]-1h-индол-3-ил]-1h-пирролмоногидрохлорид
EA200600607A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
ATE488510T1 (de) Heterocyclische derivate, deren herstellung und therapeutische verwendung
SI1845780T1 (sl) Uporaba derivatov metilfenidata
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
TW200504059A (en) Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
FR2894579B1 (fr) Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique.
GEP20063896B (en) New heterocyclic oxime compound, method for production of the same and pharmaceutical composition comprising the same
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
DE602006013828D1 (en) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
TW200612944A (en) 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors
ATE469887T1 (de) Substituierte heterocyclische verbindungen und deren verwendung zur behandlung multipler medikamentenresistenz
TW200603800A (en) 4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof
MXPA05013732A (es) Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application